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Background: Histopathological evaluation of prostatectomy specimens is crucial to decision-making and prediction
of patient outcomes in prostate cancer (PCa). Topographical information regarding PCa extension and positive
surgical margins (PSM) is essential for clinical routines, quality assessment, and research. However, local hospital
information systems (HIS) often do not support the documentation of such information. Therefore, we investigated
the feasibility of integrating a cMDX-based pathology report including topographical information into the clinical
routine with the aims of obtaining data, performing analysis and generating heat maps in a timely manner, while
avoiding data redundancy.
Methods: We analyzed the workflow of the histopathological evaluation documentation process. We then
developed a concept for a pathology report based on a cMDX data model facilitating the topographical
documentation of PCa and PSM; the cMDX SSIS is implemented within the HIS of University Hospital Muenster. We
then generated a heat map of PCa extension and PSM using the data. Data quality was assessed by measuring the
data completeness of reports for all cases, as well as the source-to-database error. We also conducted a prospective
study to compare our proposed method with recent retrospective and paper-based studies according to the time
required for data analysis.
Results: We identified 30 input fields that were applied to the cMDX-based data model and the electronic report
was integrated into the clinical workflow. Between 2010 and 2011, a total of 259 reports were generated with 100%
data completeness and a source-to-database error of 10.3 per 10,000 fields. These reports were directly reused for
data analysis, and a heat map based on the data was generated. PCa was mostly localized in the peripheral zone of
the prostate. The mean relative tumor volume was 16.6%. The most PSM were localized in the apical region of the
prostate. In the retrospective study, 1623 paper-based reports were transferred to cMDX reports; this process took
15 ± 2 minutes per report. In a paper-based study, the analysis data preparation required 45 ± 5 minutes per report.
Conclusions: cMDX SSIS can be integrated into the local HIS and provides clinical routine data and timely heat
maps for quality assessment and research purposes.
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A hospital information system (HIS) is a network-
based multi-target computational system that facilitates
information management to improve health care ma-
nagement. Physicians, researchers, patients, nurses, in-
formation technology engineers and administrators areFigure 1 Pathologic report of prostatectomy specimens. An example o
showing an adenocarcinoma of the prostate in the left lobe with extracaps
the Gleason system, the tumors are graded according to Helpap. Here, pro
which corresponds to an estimated tumor volume of 8.1 cm3 in a prostate
performed as previously described by Eminaga et al [6].all involved in the HIS. Thus, interdisciplinary interac-
tions can be realized with helpful tools provided by
the applied HIS. These interactions are essential for
disease management, especially in cancer. In this case,
we focus on prostate cancer (PCa), one of the leading
cancers in men [1]. As a therapeutic approach, manyf a morphometric mapping of a radical prostatectomy specimen
ular tumor extensions and a positive surgical margin. In addition to
state cancer takes up about 20.2% of the total area of the prostate,
of 40 cm3. The computational estimation of tumor volume was
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the prostate gland (radical prostatectomy). The histo-
pathological evaluation of prostatectomy specimens
plays a crucial role in decision-making and predicting
the patient’s outcome [2]. Consequently, diverse stan-
dardized sectioning and documentation protocols of
radical prostatectomy specimens have already been
introduced [2-4]. Here, we use a standardized protocol
for pathologic reports according to Bettendorf et al.
[4] (Figure 1). The report includes personal data and
clinical data (i.e. tumor classification, grading and ma-
lignancy) and a diagrammatic representation of the
histopathological findings in the prostate gland. It is a
practical method for documenting tumor extension
patterns and the status of the surgical margins in ra-
dical prostatectomy specimens. The surgical margin
status is important for the assessment of treatment
quality and disease management in the period after the
primary surgical therapy [5]. Additionally, the anatomic
diagram enables an approximate estimation of the ab-
solute and relative tumor volume in the prostate [4,6].
The prostate tumor volume is an independent pre-
dictor for biochemical recurrence [7,8].
In the last decade, a stepwise transformation of paper-
based patient records into electronic records has been
accomplished in most clinics. Consequently, many
researchers are now collecting data either from the HIS
or from paper-based patient records for research pur-
poses. Often these data are then stored in a separate
data container (the Dual system). This form of data col-
lection is time-consuming and can be affected by sys-
tematic errors. A study carried out by Ammenwerth
et al. showed that physicians typically spend 26.6% of
their working time in the clinic filling out documenta-
tion [9]. Furthermore, those physicians who are involved
in clinical research spend more time with documenta-
tion than with their clinical duties and activities. There-
fore, a well-defined approach is necessary to reduce data
redundancy and the time required for documentation by
reusing routine data for clinical research. A single source
concept facilitates the reduction of data redundancy and
the reuse of clinical data for research purposes [10].
The purpose of this article is to introduce the general
concept and implementation process for a single source
information system (SSIS) based on cMDX© (Clinical
Map Document based on XML). cMDX is open-source,
meets Open Packaging conventions and provides a data-
acquisition model for graphical and textual clinical infor-
mation. The graphical information is stored using a
method based on scalable vector graphics. cMDX has
already been applied to the reporting and analysis of
PCa in prostatectomy specimens [6]. In this context, we
will investigate its facility for reusing routine clinical
data for research projects. Furthermore, we will evaluatethe applied system information and compare it with
the dual source information system. Our aim is to im-
prove the information exchange between physicians
from diverse medical disciplines and the analysis of
routine health care data for research purposes and
quality management.
Methods
We began with the implementation of cMDX SSIS in
the pathology institute and in the Department of Ur-
ology at University Hospital Muenster in Germany at
the end of 2009. The implementation process was per-
formed in three stages. First, we analyzed the clinical
workflow for processing radical prostatectomy speci-
mens and documentation of histopathological eva-
luation. Then we conducted unstructured interviews
with physicians to learn their requirements and obtain
their suggestions for improving the clinical workflow.
Next, we designed the technical approach and assessed
the technical requirements. Finally, a prospective study
was conducted to evaluate the implemented informa-
tion system.
Workflow and report analysis
The diverse workflows and documentation procedures
were analyzed using methods for business workflow ana-
lysis before and after implementation of cMDX SSIS.
Pathological examination
Immediately after removal, the prostatectomy specimens
were directly delivered to the pathology institute. The
specimens were visually examined, inked, and fixed in
buffered formalin (4%) for 24-48 hours. After fixation,
the specimens were weighed with and without the sem-
inal vesicles. According to what is routinely done in the
clinic, the prostate weight in grams was equalized to its
volume in cubic centimeters (cm3). A correction factor
for tissue shrinkage after formalin fixation was ignored.
Both seminal vesicles and the base of the seminal vesi-
cles of every side were embedded separately. The ureth-
ral margin was cut as a 3-5 mm thick section parallel to
the margin, which was serially sectioned at 2 mm inter-
vals in parasagittal planes perpendicular to transverse
cutting and parallel to a segment close to the urethra.
The top margin was removed and sectioned in a similar
way. The remaining prostate gland was serially sectioned
at 5 mm intervals in transverse layers perpendicular to
the anatomical course of the urethra. The sections of the
prostate were divided into right and left halves and, de-
pending on the size of the prostate, into a front and back
part. The prostate was totally embedded. Blocks of each
slice were sectioned at 5 μm and stained with
hematoxylin and eosin to perform a microscopic exam-
ination. PCa was graded according to the Gleason
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the UICC TNM staging system [12].
Documentation of histopathological evaluation
Bettendorf designed a schematic diagram to document
the results of the histopathological evaluation of radical
prostatectomy specimens [4]. The anatomical schema
combines both seminal vesicles and a prostate gland
divided into eight defined slices (Figure 1). Each slice
expresses a fraction of the total prostate volume, which
is defined as the slice factor. This percentage distribution
was a consequence of internal pathologic observation of
the prostate volume and the prostate dimensions. Sym-
bols and icons are added to facilitate identification of the
pathological findings, which enables documentation of
the location of positive surgical margins (PSM) and
PIN 3° (Prostatic Intraepithelial Neoplasia 3 Grade).
Information such as tumor extension, areas of capsule
infiltration as well extracapsular tumor extension was
transformed from the representative slides to the dia-
grammatic schema of the prostate. Each pathology re-
port is then assigned to a unique journal number with
a text format “9999/YY” that consists of the year in
short format and the serial number of the report gen-
erated in that year.
In cMDX SSIS, the creation of electronic reports and
the computational estimation of tumor volume are per-
formed using the cMDX Editor software, as previously
described by Eminaga et al. [6]. Prior to that, the histo-
pathological evaluation was documented in paper-form,
and the tumor volume (TV) was qualitatively estimated
by visual judgment. The Interclass Correlation Coeffi-
cient (ICC) was calculated for assessing the intra- and
inter-observer reliability.
Clinical decision making
As an example of the typical clinical decision making
workflow, physicians from different medical disciplines
(urology, radiology and pathology) come together at the
weekly interdisciplinary tumor conference, where pros-
tate cancer cases are presented. During the tumor con-
ference, participants review the pathology report and
make their decisions about aftercare for convalescent
patients depending on the clinical data. The aftercare
may include regular examination at defined periods, ra-
diation therapy and/or hormone therapy. The names
and specialties of the participants, and intended proce-
dures are documented in the conference protocol. The
procedures are documented and stored in the associated
patient records. After that, the urologist visits with the
affected patients and conducts a personal conversation
with them about further procedures with respect to per-
sonal privacy. Finally, the aftercare is organized accord-
ing to treatment conditions and the clinical decision.Technical approach
We used the infrastructure of the existing informa-
tion system to establish cMDX SSIS. A virtual ma-
chine was built using the VMware Server© software
provided by the Data Center of University Muenster.
The virtual server includes the Microsoft© WindowsW
XP Professional Edition operating system and cMDX
Editor (Figure 2). This virtual server is accessible
within the internal network through the remote desk-
top. In addition, electronic reports generated with
cMDX Editor were stored on a local network hard drive.
The cMDX Editor is a c# based program and offers
functions to manage cMDX Documents. The software
encrypts sensitive data with symmetrical 256-bit rijndael
cryptography [13] to avoid data misuse by unauthorized
users. The generated reports are stored in the PDF and
cMDX file formats. The file name consists of the journal
number of the corresponding report and the patient
name. In Addition, cMDX Editor sends a HL7 MDM
message (Health Level 7 Medical Document Manage-
ment) to the current hospital information system to
transfer the pathology report saved as a PDF file into the
corresponding electronic health record (HER) in OrbisTM
(Figure 3). For this purpose, the case number or the pa-
tient identification number generated by Orbis are
obligatory.Data evaluation
In our department, we performed a prospective study
between Jan. 2010 and Dec. 2011 to evaluate the suit-
ability of cMDX SSIS for clinical routine use and re-
search. The study was made in compliance with the
World Medical Association Declaration of Helsinki on
Ethical Principles for Medical Research Involving
Human Subjects [14]. Patients gave their informed con-
sent before participating in this study. In addition, local
German regulations allow the use of clinical data col-
lected in a university hospital setting for research pur-
poses. Access to the HIS data was only authorized by
the treating physicians and the director of the clinic and
all extracted HIS data were anonymized.
We evaluated the time and steps necessary for
complete documentation and for performing analysis of
the cMDX files in the clinical study. We analyzed the
source-to-database error according to Nahm et al. [15]
and the completeness according to Chan et al. [16] to
describe data quality. In addition, we compared our
approach with the method applied in a study by
Koepke et al. [17] to generate a cumulative heat map
of the distribution of PCa, as well as with our recent
retrospective study based on cMDX [6]. The data col-
lection of both studies was performed according to the
dual source system.
Figure 2 Graphical User Interface of the cMDX Editor. The main window of the “cMDX Editor” software.
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The documentation of the pathologic reports was ana-
lyzed and it was determined that types of information
exist: textual and graphical. There are 30 inputs fields
that can be answered via the drawing area, the combi-
nation box with three to four values or with the text
box. The graphical information is stored as a vector
graphic. We developed the cMDX Editor and implemen-
ted it in the clinic over 6 months to achieve a full elec-
tronic workflow. The numbers on usage in this paper
are mainly based on the data received between Jan. 2010
and Dec. 2011.
Paper-based and cMDX-based documentation workflow
The pathology reporting workflow before implementa-
tion in the HIS began after finishing the histopatho-
logical examination. The pathologist enters the clinical
information, draws the spread pattern of PCa and marksFigure 3 Example of a HL7 MDM message. “cMDX Editor” generates thi
electronic health record.the location of PSM and PIN3 on the mapping designed
by Bettendorf. This pathologic information is then used
for disease management. When completed, the patholo-
gist makes two copies of the report for archiving and for
the tumor conference. The volume estimation of PCa is
made by visual estimation and the malignancy grade
(HELPAP) is calculated manually. The report is then
filed in the patient’s medical record. The textual data are
manually entered into a separate research database for
scientific purposes. The PCa volume estimation was not
regularly performed in the clinic before the implementa-
tion of cMDX SSIS. Therefore, in most cases the PCa
volume had to be estimated for research projects. The
Interclass Correlation Coefficients (ICC) for the estima-
tion of tumor volume for one typical single pathologist
and for different pathologists (EE, OB, MA) were 0.988
(95% CI: 0.982-0.993) and 0.999 (95% CI: 0.998-0.999),
respectively.s message to transfer the pathology report into the corresponding
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port were implemented in the local HIS and the me-
dical staff received on-the-job-training. The training
duration was 15 minutes and comprised all aspects
related to the accessing and application of the cMDX
templates available in the HIS. Two pathologists parti-
cipated in this training. In the new workflow after the
histopathological examination, the pathologist calls the
program “cMDX Editor” and selects the needed tem-
plate. The pathologist then documents the results in
the cMDX report. The documentation of the pathology
report took approximately 10 ± 2 minutes. In addition,
the software performs the computational volume esti-
mation of PCa. The report is stored in a defined net-
work drive after the user confirms the Save command.
During the meeting of the tumor conference, the
reports are projected on the display wall and are
viewed by participants. If the physician enters the
related patient’s case ID, the report is stored in the
patient’s electronic health record (EHR). Furthermore,
the software can print the report automatically, if the
user activates this function in the “option setting”. In
case the pathologist has to complete or modify the re-
port, he/she can call up the desired report from the
network drive. All reports are accessible for authorized
users within the HIS and the user can search for the
required report by the journal number. Figure 4
demonstrates the workflow of cMDX documentation
after the implementation of cMDX SSIS in the HIS
has been completed.Figure 4 Workflow of cMDX documentation after the implementation
specimen is prepared for histopathological examination. After that, the pat
the cMDX Editor. The cMDX Editor transformed the PDF file to the corresp
during the tumor conference. The background colors symbolize the involv
pathology, green for radiology, and lilac for cMDX Editor.Data quality
We focused on the mandatory items (e.g. TNM classifi-
cation system, Gleason score, and tumor volume) for
pathology reporting to assist the report completeness
rate. During a two-year period (Jan. 1, 2010 until Dec.
31, 2011) we matched the number of patients who
underwent radical prostatectomy with the number of
completed pathology reports. In addition, at one-month
intervals we determined the number of pathology
reports generated in the defined period to assess the
user acceptance of cMDX SSIS. Two hundred fifty-nine
patients with prostate cancer were treated with radical
prostatectomy. At same time, 259 cMDX-based patho-
logy reports were generated in the study period. The
number of cMDX reports was increased monthly
(Figure 5). All pathology reports included all mandatory
items. Therefore, we achieved a report completeness rate
of 100% by using cMDX SSIS. Before applying the auto-
matic file naming to the cMDX reports, a total of 4320
data fields were audited; six reports had an error in the
file name and the journal number, which were corrected
without any problem; this represents a source-to-
database error rate of 13.9 errors per 10,000 fields. After
implementing the automatic file naming in 2011, we
identified only 2 errors in 3450 fields, yielding an esti-
mated error rate of 5.8 errors per 10,000 fields. The dif-
ference between both error rates is significant (p < 0.000).
We transferred 1623 pathology reports generated be-
tween 1999 and 2009 into cMDX format; 10 pathology
reports were not readable. The prostate volume of eachof cMDX SSIS in HIS. After complete removal of the prostate, the
hological information and the tumor extension are documented using
onding electronic health record. This cMDX report is also presented
ed medical disciplines and software: Yellow represents urology, blue for
Figure 5 Cumulative frequency of cMDX-based pathology reports since Jan. 2010. A noticeable increase can be seen in the number of
cMDX-based pathology reports.
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had to be completed from another data sheet.
Simplified use in clinical research
A total of 259 reports were enrolled in our study. The
cMDX reports were evaluated by an analysis tool called
“cMDX Analyzer”. Acquired data were then exported as
CSV files (comma-separated values) into the statistical
program IBM SPSS Statistic 19 (SPSS Inc., Chicago, IL,
USA) to perform descriptive statistics to characterize the
patient population (Table 1). The mean relative tumor
volume was 16.6% (range: 0-63.1%). The analysis tool
generates a color diagram representing the spread pat-
terns of prostate cancers (Figure 6). The accuracy and
precision of these spatial localizations was evaluated on
10 prostatectomy specimens. No deviation in the loca-
tion of PCa foci was found in the heat map in compari-
son to the original reports. In most cases, PCa affects
the posterior lateral region of prostate. The positive sur-
gical margins are mostly localized in the apical region of
the prostate. As a result, researchers can reuse routine
medical data stored in cMDX SSIS for study. The ana-
lysis of all 259 reports took an average of 26 ± 3 sec on a
notebook computer with the following hardware specifi-
cations: Intel© i5 Core, 4 GB 1333 MHz DDR3 RAM,128 GB SSD, Intel© HD Graphics 3000 with 384 MB
DDR3 SDRAM.
Additionally, during the study we estimated the time
elapsed from generation of the pathology report of pros-
tatectomy specimens to receiving the report by the uro-
logists and then to data analysis. The cMDX reports are
available and accessible immediately after the documen-
tation is completed. By contrast, the paper-based reports
were mostly received and previewed by urologists for
the first time during the weekly tumor conference.
The data acquired in cMDX SSIS can be analyzed and
reused in a clinical study without any major preparation.
Recently, the pathology reports were stored in the corre-
sponding patient records only in paper form. In our last
study, 255 of 1623 paper-based pathology reports gene-
rated between Jan. 1999 and Sep. 2009 were transformed
into electronic form. All reports were scanned and saved
as images (i.e. JPEG or BMP); the images were processed
using freeware photo editing software called Paint.Net
(dotPDN LLC, USA) [17]; here, the PCa foci had been
distinguished from other shapes and were highlighted.
Then, we converted these images into cMDX document
format using cMDX Editor (Additional files 1 and 2).
The whole process took 15 ± 2 minutes per report on
average.
Table 1 Cohort characteristics
Frequency (%)
Patients 259 (100)
Pathologic tumor stage
pT1a 7 (2.7)
pT2a 26 (10.0)
pT2b 5 (1.9)
pT2c 132 (51.0)
pT3a 52 (20.1)
pT3b 36 (13.9)
ypT4 1 (0.4)
Lymph node status
pNx 1 (0.4)
pN0 237 (91.5)
pN1 21 (8.1)
Surgical margin status
Rx 2 (0.8)
R0 197 (76.1)
R1 60 (23.2)
Lymph vessel involvement
Lx 1 (0.4)
L0 188 (72.6)
L1 70 (27.0)
Vein involvement
Vx 1 (0.4)
V0 235 (90.7)
V1 23 (8.9)
Gleason Score
5 5 (1.9)
6 53 (20.5)
7 151 (58.3)
8 5 (1.9)
9 43 (16.6)
Cannot be estimated 2 (0.8)
HELPAP
Ib 4 (1.5)
IIa 78 (30.1)
IIb 96 (37.1)
IIIa 26 (10.0)
IIIb 53 (20.5)
Cannot be estimated 2 (0.8)
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copied with a magnification factor of 141% on transpa-
rent follies. These follies were then holed on the com-
puter screen, where a commercial spreadsheet program
was also opened. The spreadsheet contains the definedinput areas representing the anatomical schema of
the pathology report. The PCa foci were transferred
manually into the corresponding areas on the display
screen as in the original. This process tool approxi-
mately 45 ± 5 minutes per report in average.
Discussion
With cMDX SSIS, it is feasible to generate heat maps of
the spread patterns of PCa from routine data. The ana-
lysis tool enables the analysis of graphical data to obtain
a resulting image file with the heat map and CSV files
containing clinical data and analysis results. The data
analysis is performed in compliance with data privacy
regulations. The applied tools are user-friendly and well-
accepted by physicians. Therefore, cMDX SSIS is a prac-
tical approach to obtain timely heat maps and results
from the current data without any major preparation.
Previously, the physicians had to fit data from routine
documentation to perform analysis. This procedure is
time-consuming and can cause systematic errors during
data fitting. The goal of improving the primary informa-
tion system is well known, but the implementation of
single source systems is not common [10]. We con-
ducted a PubMed search using the key words “heat map
and prostate cancer”, “heat map and documentation”
and “map and prostate cancer”. Here, we did not find
any similar approaches to the implementation of this
form of documentation in the HIS that can provide
timely heat maps.
The anatomical representation of the prostatic gland
enables the collection and analysis of the spread pattern
of PCa as well the status of the surgical margins. Such
information is necessary to optimize the biopsy strategy,
so that the detection rate of PCa can be increased
[18-20]. In addition, the status of the surgical margins
plays an essential role in treatment and quality ma-
nagement assessments, which is one of the important
conditions for certification of prostate centers [5]. The
tumor volume is presumably an important prognostic
indicator for predicting prostate cancer recurrence fol-
lowing surgery and therefore must be mentioned in
the pathologic reports [8]. The pathology report can
be denoted as a supportive tool for decision-making in
cancer management and therefore must be clearly
structured and informative for physicians. With cMDX
SSIS, we have achieved the creation of pathology
reports within a short turnaround time.
The measured data quality, especially the complete-
ness of the documented items per form, is high. The
completeness of the electronic forms in the HIS (current
documentation) was found to be 100%. We presume that
clinical routine data are documented regularly in each
patient. By contrast, the clinical data not related to the
clinical routine are commonly not documented; however
Figure 6 Heat map diagram representing the patterns of spread of prostate cancer and positive surgical margins. The cumulative
diagram of spread patterns of prostate cancer in 259 prostatectomy specimens. The color gradient represents the frequency rate of PCa foci in
the various locations (blue: low frequency; red: high frequency). * denotes the frequency rate of positive surgical margins in each slice.
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search purposes. Furthermore, the retrospective study
seems to have lower data completeness than the pro-
spective study because in a retrospective study, patients
with missing or incomplete data may be present.
According to Chan et al., the data completeness varied
considerably across studies and that even in the same
organization, the amount of missing data was variable
[16]. Nahm et al. concluded that medical record abstrac-
tion is the most significant source of errors and should
be controlled and managed during the course of clinical
trials; the acceptance criteria for analytical variables were
10 errors per 10,000 fields and zero errors per 10,000
fields [15]. The source-to-database error rate in the
documentation process is acceptably low (on average,
10.3 errors per 10,000 fields). We assume that the regu-
lar evaluation of pathology reports during the tumor
conference is the main reason for the low error rate.
Since applying the automatic file naming of cMDX
reports, the source-to-database error rate was decreased
significantly. Therefore, the automation of standardized
well-defined procedures may reduce the error rate in thedocumentation process. Nevertheless, further investiga-
tions are needed to validate this statement.
The transformation of paper-based documentation to
electronic form is time consuming and mostly asso-
ciated with data incompleteness. Furthermore, addi-
tional data sources, if available, are necessary to achieve
data completeness.
cMDX SSIS was implemented in a commercial HIS
and is therefore applicable to all other customers using
the same HIS. In addition, cMDX supports standard
document formats such as HL7 and CDA (clinical
document architecture) and can store pictures and
images [6]. The pathological information in prostatec-
tomy specimens is now available in the HIS for many
patients. Attributes such as tumor staging, Gleason
score, and tumor extension are documented in a struc-
tured way, which can be used as inclusion or exclusion
criteria for patient recruitment in clinical trials. The
supplementary cMDX Editor tool is not currently
available for public download, but the interested reader
can contact the corresponding author to obtain a copy
of the tool for use.
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This article focused primarily on pathology reports of
prostatectomy specimens. The statement of transferabi-
lity of cMDX SSIS to other clinical fields is therefore
limited. The technical approach described here may be
accompanied by technical failures, which requires appro-
priate handling to keep the system working without
interruption. Any technical interruption could result in
data incompleteness and disrupted workflows in clinical
routines. Thus the system requires continual monitoring
and periodic maintenance.
Conclusions
cMDX SSIS facilitates the electronic documentation of
pathology reports. Implementation of this system into
the local HIS is feasible; it enables the reuse of the
pathological information for quality management and re-
search purposes as well for generating timely heat maps
from routine clinical data.
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